HbA1C as a marker of retrograde glycaemic control... (2020 study) Skip to main content
Case Study Journal of clinical pharmacy and therapeutics 2020

HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.

Gluvic Z, Obradovic M, Lackovic M, Samardzic V, Tica Jevtic J, Essack M, et al., Journal of clinical pharmacy and therapeutics, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors described one man with diabetes and thalassaemia who was treated in hospital, and they reviewed the literature on blood sugar markers in people with thalassaemia.

What They Found

This case report describes a male patient with diabetes and thalassaemia whose HbA1C value looked acceptable even though his five-point glycaemic profile was unacceptable. He was hospitalized with distal neuropathic pain and a trophic ulcer on his right toe. After insulin therapy was started at the same time as ulcer management with hyperbaric oxygen, he showed improved glycaemic control and ulcer healing, and he was discharged. The abstract does not give numbers, pressures or session counts. It concludes that in thalassaemia and haemoglobinopathies, HbA1C should be measured with a different method, or measured together with fructosamine, because HbA1C and the five-point profile did not agree.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a report of one patient, and because insulin and hyperbaric oxygen were started together, the abstract cannot separate the effect of each treatment.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Study
Category Wound Care
Source Pubmed
PubMed ID 31736110
Year Published 2020
Journal Journal of clinical pharmacy and therapeutics
MeSH Terms Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Foot; Fructosamine; Glycated Hemoglobin; Humans; Hyperbaric Oxygenation; Hypoglycemic Agents; Insulin; Male; beta-Thalassemia

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology